Obesity and oxidative stress intensify psoriasis through activating IL-17/IL-23 pathway

被引:0
|
作者
Vikasari, Suci Nar [1 ,3 ]
Sukandar, Elin Yulinah [3 ]
Suciati, Tri [2 ]
Adnyana, I. Ketut [2 ]
机构
[1] Inst Teknol Bandung, Sch Pharm, Doctoral Program Pharm, Bandung, Indonesia
[2] Inst Teknol Bandung, Sch Pharm, Bandung, Indonesia
[3] Univ Jenderal Achmad Yani, Fac Pharm, Cimahi, Indonesia
来源
PHYSIOLOGY AND PHARMACOLOGY | 2024年 / 28卷 / 01期
关键词
Psoriasis; Autoimmune; Obese; Oxidative stress; IL-17/IL-23; pathway; PATHOPHYSIOLOGY; PATHOGENESIS; UPDATE;
D O I
10.61186/phypha.28.1.18
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Psoriasis is an autoimmune disease characterized by keratinocyte hyperproliferation and skin thickening. Psoriasis is caused by a complicated interaction between the innate and acquired immune systems. In the skin, this reaction produces abnormal T helper cell (Th1, Th17, and Th23) reactivation. Keratinocyte hyperproliferation is caused by increased cell (TNF-alpha), and interferon-gamma (INF-gamma). Obesity, free fatty acids, microorganisms in the skin and digestive tract, free radicals in the body, and the cardiovascular system are also essential variables in psoriasis. Several variables influence the cytokine activation of the IL17/IL-23 pathway. Obesity, which is marked by changes in lipid profile in psoriasis patients, is linked to increased oxidative stress and the generation of proinflammatory cytokines, both of which can potentially trigger psoriasis relapse. Antioxidant-rich diet and intake can be employed as one of the stages in preventing psoriasis recurrence.
引用
收藏
页码:18 / 26
页数:9
相关论文
共 50 条
  • [41] Risk for Deep Fungal Infections During IL-17 and IL-23 Inhibitor Therapy for Psoriasis
    Lee, Michael P.
    Wu, Kevin K.
    Lee, Erica B.
    Wu, Jashin J.
    CUTIS, 2020, 106 (04): : 199 - +
  • [42] EXPRESSION LEVELS OF IL-17, IL-22 AND IL-23 RECEPTORS IN FOUR OSTEOBLAST MODELS AND THE EFFECTS OF IL-17, IL-22 AND IL-23 ON OSTEOBLASTS
    Zhang, J. -R.
    Dai, S. -M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 627 - 628
  • [43] Onset of Plaque Psoriasis Treatment Responses With Anti IL-17/IL-23 Biologic Therapies
    Fried, Richard G.
    Lebwohl, Mark
    Bettencourt, Miriam
    Koo, John
    Jacobson, Abby
    JOURNAL OF DRUGS IN DERMATOLOGY, 2022, 21 (08) : 854 - 860
  • [44] IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
    Li, Hao
    Tsokos, George C.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2021, 60 (01) : 31 - 45
  • [45] The Role of IL-23/IL-17 Axis in Lupus Nephritis
    Zhang, Zheng
    Kyttaris, Vasileios C.
    Tsokos, George C.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (05): : 3160 - 3169
  • [46] IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
    Hao Li
    George C. Tsokos
    Clinical Reviews in Allergy & Immunology, 2021, 60 : 31 - 45
  • [47] Therapeutic potential of targeting IL-17 and IL-23 in sepsis
    Bosmann, Markus
    Ward, Peter A.
    CLINICAL AND TRANSLATIONAL MEDICINE, 2012, 1
  • [48] Erratum: The IL-23–IL-17 axis in inflammatory arthritis
    Erik Lubberts
    Nature Reviews Rheumatology, 2015, 11 : 562 - 562
  • [49] Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production
    Xu Mingli
    Noriko, Morishima
    Izuru, Mizoguchi
    Yukino, Chiba
    Koji, Fujita
    Masahiko, Kuroda
    Yoichiro, Iwakura
    Daniel, Cua J.
    Koji, Yasutomo
    Junichiro, Mizuguchi
    Takayuki, Yoshimoto
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [50] Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production
    Xu, Mingli
    Morishima, Noriko
    Mizoguchi, Izuru
    Chiba, Yukino
    Fujita, Koji
    Kuroda, Masahiko
    Iwakura, Yoichiro
    Cua, Daniel J.
    Yasutomo, Koji
    Mizuguchi, Junichiro
    Yoshimoto, Takayuki
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (10) : 2828 - 2839